(Total Views: 424)
Posted On: 07/23/2019 5:21:46 PM
Post# of 153986
Celgene just in-licensed a monoclonoal antibody from small biopharma Jounce, which is up 40% in the AH.
Jounce gets $50M upfront,plus $480M in milestone payments.
Celgene is responsible for all development and commercialization activities.
LM
Jounce gets $50M upfront,plus $480M in milestone payments.
Celgene is responsible for all development and commercialization activities.
LM
(2)
(0)
The Lawman
style="color:red">The Lawman"color:red">The Lawman:red">The LawmanThe Lawmanspan>Lawmanawmanimg]
